Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adva Kochavi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Cell|December 15, 2022
Proteome diversification by mRNA translation in cancerAdva Kochavi, Domenica Lovecchio, William James Faller, et al.
Cellular Signalling|February 11, 2026
Oncogenic crosstalk between ErbB2, nucleolin and RasGal Zysman, Adva Kochavi, Roni Haklai, et al.
NAR Cancer|November 5, 2025
Exploiting nanopore sequencing advances for tRNA sequencing of human cancer modelsAdva Kochavi, Arno Velds, Maya Suzuki, et al.
Nucleic Acids Research|November 26, 2024
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancerAdva Kochavi, Remco Nagel, Pierre-Rene Körner, et al.
Cancer Research|May 7, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope ProductionRemco Nagel, Adva Kochavi, Karine Flem-Karlsen, et al.
Science (New York, N.Y.)|May 16, 2024
DNA damage induces p53-independent apoptosis through ribosome stallingNicolaas J Boon, Rafaela A Oliveira, Pierré-René Körner, et al.
Immunity|January 4, 2025
Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translationJulien Champagne, Morten M Nielsen, Xiaodong Feng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Cell|December 15, 2022
Proteome diversification by mRNA translation in cancerAdva Kochavi, Domenica Lovecchio, William James Faller, et al.
Cellular Signalling|February 11, 2026
Oncogenic crosstalk between ErbB2, nucleolin and RasGal Zysman, Adva Kochavi, Roni Haklai, et al.
NAR Cancer|November 5, 2025
Exploiting nanopore sequencing advances for tRNA sequencing of human cancer modelsAdva Kochavi, Arno Velds, Maya Suzuki, et al.
Nucleic Acids Research|November 26, 2024
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancerAdva Kochavi, Remco Nagel, Pierre-Rene Körner, et al.
Cancer Research|May 7, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope ProductionRemco Nagel, Adva Kochavi, Karine Flem-Karlsen, et al.
Science (New York, N.Y.)|May 16, 2024
DNA damage induces p53-independent apoptosis through ribosome stallingNicolaas J Boon, Rafaela A Oliveira, Pierré-René Körner, et al.
Immunity|January 4, 2025
Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translationJulien Champagne, Morten M Nielsen, Xiaodong Feng, et al.
Pageof 1